Heterologous prime–boost vaccinations for poverty-related diseases: advantages and future prospects
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heterologous prime–boost vaccinations for poverty-related diseases: advantages and future prospects
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 8, Issue 5, Pages 577-592
Publisher
Informa UK Limited
Online
2009-04-27
DOI
10.1586/erv.09.14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Persistence of the immune response induced by BCG vaccination
- (2008) Rosemary E Weir et al. BMC INFECTIOUS DISEASES
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
- Single-dose immunogenicity and protective efficacy of simian adenoviral vectors againstPlasmodium berghei
- (2008) Arturo Reyes-Sandoval et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Protective CD8+T cells againstPlasmodiumliver stages: immunobiology of an ‘unnatural’ immune response
- (2008) Michael Glen Overstreet et al. IMMUNOLOGICAL REVIEWS
- Early T-cell responses in tuberculosis immunity
- (2008) Gary M. Winslow et al. IMMUNOLOGICAL REVIEWS
- Impact of Recombinant Adenovirus Serotype 35 Priming versus Boosting of a Plasmodium falciparum Protein: Characterization of T- and B-Cell Responses to Liver-Stage Antigen 1
- (2008) A. Rodriguez et al. INFECTION AND IMMUNITY
- Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria
- (2008) F. H. A. Osier et al. INFECTION AND IMMUNITY
- Activation of a dendritic cell–T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells
- (2008) Matthieu Perreau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- (2008) Alexandre Harari et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Broad Immunogenicity of a Multigene, Multiclade HIV‐1 DNA Vaccine Boosted with Heterologous HIV‐1 Recombinant Modified Vaccinia Virus Ankara
- (2008) Eric Sandström et al. JOURNAL OF INFECTIOUS DISEASES
- A New Recombinant Bacille Calmette‐Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis‐Specific Immunity in Human Volunteers
- (2008) Daniel F. Hoft et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa
- (2008) Tony Hawkridge et al. JOURNAL OF INFECTIOUS DISEASES
- Antibodies to Pre‐erythrocyticPlasmodium falciparumAntigens and Risk of Clinical Malaria in Kenyan Children
- (2008) Chandy C. John et al. JOURNAL OF INFECTIOUS DISEASES
- DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response Profiles
- (2008) K. S. Cox et al. JOURNAL OF VIROLOGY
- Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys
- (2008) J. Liu et al. JOURNAL OF VIROLOGY
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
- Challenges in the development of an HIV-1 vaccine
- (2008) Dan H. Barouch NATURE
- Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
- (2008) Jinyan Liu et al. NATURE
- Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans
- (2008) David I Watkins et al. NATURE MEDICINE
- Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa
- (2008) Roger H. Brookes et al. PLoS One
- rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector
- (2008) Isabelle Magalhaes et al. PLoS One
- Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
- (2008) Kent E. Kester et al. VACCINE
- Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial
- (2007) Jahit Sacarlal et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started